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Figure 1. Schematic representation of B-cell development and 
its relationship to B-cell lymphomagenesis. The current study 
focuses on the relationship between Burkitt lymphoma and 


























Burkitt lymphoma expression profiles n = 21
High-Grade lymphoma expression profiles n = 9 
Figure 2. Pictorial depiction of workflow for obtaining gene 
expression-based immune-cell estimations in B-cell 
lymphoma patient samples.  
Figure 3. High-Grade B-cell lymphoma (HGL) and Burkitt
lymphoma (BL) differ in malignant B-cell signatures. (A) 
Boxplot of Memory B-cell Score from xCell in HGL and BL 
patient samples. (B) Boxplot of Plasma Cell Score from 



























































Figure 4. High-Grade B-cell lymphoma (HGL) and Burkitt
lymphoma (BL) differ in tumor microenvironment T-cell 
signatures. (A) Boxplot of T-regulatory (Treg) Score from 
xCell in HGL and BL patient samples. (B) Boxplot of T-
Helper 1 (TH1) Score from xCell in HGL and BL 





• In the patients affected in combination with traditional chemotherapy and 
other novel agents play a huge role in understanding this diverse group of 
diseases. these results suggest differential microenvironments in these 
malignancies which could be exploited in therapeutic strategies as T-
regulatory and T-helper 1 subsets can influence anti-tumor responses.
• Knowing this information could regulate inflammation, decreasing the 
potential for pro-tumor effects in patients. 
Abstract
Intro: B-cell lymphomas are a group of diseases that originate from the B cell compartment of your white 
blood cells. B-cell lymphoma and High-Grade Lymphoma are difficult to distinguish by pathologists 
based on morphology but have been shown to have very different expression profiles by suggesting 
these lymphomas come from different stages of B-cell development.
M&M:  CIBERSORTx is an analytical tool to impute gene expression profiles and provide an estimation 
of the abundances of member cell types in a mixed cell population, using gene expression data.
Results: A program called xCell was utilized to see that High-Grade Lymphoma cases were enhanced 
for memory B-cell marks while Burkitt Lymphoma cases were improved for plasma cell signatures 
suggesting a potential difference in the normal cell counterpart. For immune-cell signatures in the 
microenvironment, I observed that High Grade Lymphoma samples had a statistically significant 
increase in T-regulatory cell signatures
Conclusions: I observed that High Grade Lymphoma samples had a statistically significant increase in T-
regulatory cell signatures while Burkitt Lymphoma samples had a statistically significant increase in T-
helper 1 signatures. Taken together, these results suggest differential microenvironments in these 
malignancies which could be exploited in therapeutic strategies as T-regulatory and T-helper 1 subsets 
can influence anti-tumor responses. 
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